{"symbol": "CLSD", "companyName": "Clearside Biomedical Inc.", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.clearsidebio.com", "description": "Clearside Biomedical Inc is a clinical biopharmaceutical company. It is engaged in developing drug therapies to treat blinding diseases of the eye. Its product candidates focuses on diseases affecting the retina.", "CEO": "Daniel H. White", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}